Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 220991-32-2
2. Onsior
3. Robenacoxib [inn]
4. 2-(5-ethyl-2-((2,3,5,6-tetrafluorophenyl)amino)phenyl)acetic Acid
5. 2-[5-ethyl-2-(2,3,5,6-tetrafluoroanilino)phenyl]acetic Acid
6. Chebi:76269
7. Cgs 34975
8. Z588009c7c
9. (5-ethyl-2-((2,3,5,6-tetrafluorophenyl)amino)phenyl)acetic Acid
10. Robenacoxibum
11. {5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic Acid
12. Robenacoxib [mi]
13. Schembl6036596
14. Zinc7562
15. Chembl2107774
16. Robenacoxib [green Book]
17. Unii-z588009c7c
18. Dtxsid90176607
19. Bcp23758
20. Mfcd27966869
21. Db11455
22. Ncgc00532515-01
23. Robenacoxib [ema Epar Veterinary]
24. Cs-0065148
25. Ft-0674451
26. C20708
27. A902615
28. J-014494
29. Q7341121
30. 5-ethyl-2-(2',3',5',6'-tetrafluoroanilino)phenylacetic Acid
31. 5-ethyl-2-(2', 3', 5', 6'-tetrafluoroanilino)phenylacetic Acid
32. 5-ethyl-2-(2', 3',5',6'-tetrafluoroanilino)phenylacetic Acid
33. 5-ethyl-2-(2',3',5', 6'-tetrafluoroanilino)phenylacetic Acid
34. 5-ethyl-2-(2',3',5',6'-tetrafluoroanilino) Phenylacetic Acid
Molecular Weight | 327.27 g/mol |
---|---|
Molecular Formula | C16H13F4NO2 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 327.08824131 g/mol |
Monoisotopic Mass | 327.08824131 g/mol |
Topological Polar Surface Area | 49.3 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 398 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cats (tablets):
For the treatmentRelief of pain and inflammation associated with acute andor chronic musculo-skeletal disorders.
For the reduction of moderate pain and inflammation associated with orthopaedic surgery.
Dogs (tablets):
For the Ttreatment of pain and inflammation associated with chronic osteoarthritis .
For the treatment of pain and inflammation associated with soft tissue surgery.
Cats and dogs (solution for injection):
For the Ttreatment of pain and inflammation associated with orthopaedic or soft tissue surgery.
QM01AH91
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
NDC Package Code : 86055-0015
Start Marketing Date : 2019-06-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6334
Submission : 2019-09-25
Status : Active
Type : II
NDC Package Code : 86055-0015
Start Marketing Date : 2019-06-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69169-126
Start Marketing Date : 2024-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6334
Submission : 2019-09-25
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
Reply
03 Jul 2023
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Robenacoxib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Robenacoxib, including repackagers and relabelers. The FDA regulates Robenacoxib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Robenacoxib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Robenacoxib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Robenacoxib supplier is an individual or a company that provides Robenacoxib active pharmaceutical ingredient (API) or Robenacoxib finished formulations upon request. The Robenacoxib suppliers may include Robenacoxib API manufacturers, exporters, distributors and traders.
click here to find a list of Robenacoxib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Robenacoxib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Robenacoxib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Robenacoxib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Robenacoxib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Robenacoxib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Robenacoxib suppliers with NDC on PharmaCompass.
Robenacoxib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Robenacoxib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Robenacoxib GMP manufacturer or Robenacoxib GMP API supplier for your needs.
A Robenacoxib CoA (Certificate of Analysis) is a formal document that attests to Robenacoxib's compliance with Robenacoxib specifications and serves as a tool for batch-level quality control.
Robenacoxib CoA mostly includes findings from lab analyses of a specific batch. For each Robenacoxib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Robenacoxib may be tested according to a variety of international standards, such as European Pharmacopoeia (Robenacoxib EP), Robenacoxib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Robenacoxib USP).
LOOKING FOR A SUPPLIER?